Vaccination Coverage by Age 24 Months Among Children Born in 2015 and 2016

National Immunization Survey-Child, United States, 2016-2018

Holly A. Hill, MD, PhD; James A. Singleton, PhD; David Yankey, PhD; Laurie D. Elam-Evans, PhD; S. Cassandra Pingali, MPH, MS; Yoonjae Kang, MPH

Disclosures

Morbidity and Mortality Weekly Report. 2019;68(41):913-918. 

In This Article

National Vaccination Coverage

Coverage by age 24 months was ≥90% for ≥3 doses of poliovirus vaccine (92.7%), ≥1 dose of MMR (90.4%), ≥3 doses of HepB (91.0%), and ≥1 dose of varicella vaccine (90.0%) (Table 1). Compared with estimates for children born in 2013 and 2014, coverage for children born during 2015–2016 increased for the HepB birth dose (3.2 percentage points), ≥1 dose of HepA (1.5 percentage points), and ≥2 doses of influenza vaccine (3.6 percentage points). Coverage with ≥2 HepA doses by age 35 months increased from 74.0% for children born during 2013–2014 to 76.6% for children born during 2015–2016. Children were least likely to be up to date by age 24 months with ≥2 doses of influenza vaccine (56.6%) and the combined 7-vaccine series†† (68.5%).

†† The combined 7-vaccine series (4:3:1:3*:3:1:4) includes ≥4 doses of diphtheria and tetanus toxoids and acellular pertussis vaccine; ≥3 doses of poliovirus vaccine; ≥1 dose of measles-containing vaccine; ≥3 or ≥4 doses (depending upon product type) of Haemophilus influenzae type b conjugate vaccine; ≥3 doses of hepatitis B vaccine; ≥1 dose of varicella vaccine; and ≥4 doses of pneumococcal conjugate vaccine.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....